தாமஸ் பர்னெல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தாமஸ் பர்னெல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தாமஸ் பர்னெல் Today - Breaking & Trending Today

Interpace Biosciences Announces First Quarter 2021 Financial and Business Results


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Interpace Biosciences Announces First Quarter 2021 Financial and Business Results
Interpace Biosciences, Inc.May 11, 2021 GMT
 

Q1 Revenue of $9.8 Million is Company’s Highest as Combined Molecular Diagnostics and Pharma Services Business
 
 
 
ADVERTISEMENT
PARSIPPANY, NJ, May 11, 2021 (GLOBE NEWSWIRE) Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fiscal quarter ended March 31, 2021 and provided a business and financial update.
“We are very pleased with our first quarter operating results which are on track and in accordance with our growth, restructuring and reprioritization plan,” said President and CEO Thomas Burnell. “As we progress further into 2021, we expect to build on this momentum and will be focused on opportunities related to expanded pri ....

United States , New Jersey , North Carolina , Interpace Biosciences , Tom Freeburg , Interpace Bioscience , Thomas Burnell , Guggenheim Securities , Company Annual Report On Form , Interpace Biosciences Inc , Laboratory Analysis , Pharma Services Business , Interpace Pharma Solutions , University Of New Jersey , Securities Exchange , Xifin Inc , Combined Molecular Diagnostics , Pharma Services , Exceed Full Year , First Quarter , Continuing Operations , Sales Outstanding , Fourth Quarter , Blue Cross Shield , State University , Massachusetts General Hospital ,

Interpace Biosciences Announces Path Forward in Letter to Shareholders Nasdaq:IDXG


Dear Shareholders,
As the newly appointed President and CEO of Interpace I want to take a moment to formally introduce myself and share the new vision and mission for this Company as it relates to our core capabilities, growth prospects and directional outlook for this year and beyond. I joined Interpace with significant leadership experience, including with several specialty clinical laboratories. This includes serving as President & CEO of Boston Heart Diagnostics, Viracor-IBT Laboratories and Eurofins Scientific, Inc. I bring to the table important experience in developing and implementing successful commercial strategies, short and long term financing options, improving reimbursement, overall corporate efficiency, and employee effectiveness – all critical assets as the Company and product pipeline continue to evolve here at Interpace. ....

United States , North Carolina , Interpace Biosciences , Megan Paul , Interpace Bioscience , Thomas Burnell , Eurofins Scientific Inc , Interpace Biosciences Inc , Interpace Pharma Solutions , Securities Exchange , Edison Group , Boston Heart Diagnostics , Eurofins Scientific , New Haven , Chief Executive Officer , Interpace Diagnostics , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Risk Factor , Annual Report , Current Reports , Quarterly Reports , What Time Is It , Free Fire Vs Pubg , Look Like ,